Berstein, L. M. (2019). Is cancer incidence modified by SGLT2 inhibitors? Endocrinology Research Centre.
Cita Chicago Style (17a ed.)Berstein, Lev M. Is Cancer Incidence Modified by SGLT2 Inhibitors? Endocrinology Research Centre, 2019.
Cita MLA (8a ed.)Berstein, Lev M. Is Cancer Incidence Modified by SGLT2 Inhibitors? Endocrinology Research Centre, 2019.
Precaución: Estas citas no son 100% exactas.